BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19953551)

  • 1. Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis.
    Abbott KL; Lim JM; Wells L; Benigno BB; McDonald JF; Pierce M
    Proteomics; 2010 Feb; 10(3):470-81. PubMed ID: 19953551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of serum biomarkers implicated in the onset and progression of serous ovarian cancer in a rat model using iTRAQ technique.
    Huang Y; Zhang X; Jiang W; Wang Y; Jin H; Liu X; Xu C
    Eur J Obstet Gynecol Reprod Biol; 2012 Nov; 165(1):96-103. PubMed ID: 22818854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS.
    Wu J; Xie X; Liu Y; He J; Benitez R; Buckanovich RJ; Lubman DM
    J Proteome Res; 2012 Sep; 11(9):4541-52. PubMed ID: 22827608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of glycan variation on glycoproteins from serum by the reverse lectin-based ELISA assay.
    Wu J; Zhu J; Yin H; Buckanovich RJ; Lubman DM
    J Proteome Res; 2014 Apr; 13(4):2197-204. PubMed ID: 24575722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling.
    Dhar C; Ramachandran P; Xu G; Pickering C; Čaval T; Wong M; Rice R; Zhou B; Srinivasan A; Aiyetan P; Chu CW; Moser K; Herzog TJ; Olawaiye AB; Jacob F; Serie D; Lindpaintner K; Schwarz F
    Br J Cancer; 2024 Jun; 130(10):1716-1724. PubMed ID: 38658783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian Tumors.
    Vitiazeva V; Kattla JJ; Flowers SA; Lindén SK; Premaratne P; Weijdegård B; Sundfeldt K; Karlsson NG
    PLoS One; 2015; 10(6):e0130197. PubMed ID: 26075384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
    Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
    World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot.
    Qiu Y; Patwa TH; Xu L; Shedden K; Misek DE; Tuck M; Jin G; Ruffin MT; Turgeon DK; Synal S; Bresalier R; Marcon N; Brenner DE; Lubman DM
    J Proteome Res; 2008 Apr; 7(4):1693-703. PubMed ID: 18311904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Robust and Versatile Automated Glycoanalytical Technology for Serum Antibodies and Acute Phase Proteins: Ovarian Cancer Case Study.
    O'Flaherty R; Muniyappa M; Walsh I; Stöckmann H; Hilliard M; Hutson R; Saldova R; Rudd PM
    Mol Cell Proteomics; 2019 Nov; 18(11):2191-2206. PubMed ID: 31471495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoproteomic identification of potential glycoprotein biomarkers in ovarian cancer proximal fluids.
    Kuzmanov U; Musrap N; Kosanam H; Smith CR; Batruch I; Dimitromanolakis A; Diamandis EP
    Clin Chem Lab Med; 2013 Jul; 51(7):1467-76. PubMed ID: 23241603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A serum based analysis of ovarian epithelial tumorigenesis.
    Nolen B; Marrangoni A; Velikokhatnaya L; Prosser D; Winans M; Gorelik E; Lokshin A
    Gynecol Oncol; 2009 Jan; 112(1):47-54. PubMed ID: 19007974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoproteomic analyses of ovarian cancer cell lines and sera from ovarian cancer patients show distinct glycosylation changes in individual proteins.
    Li B; An HJ; Kirmiz C; Lebrilla CB; Lam KS; Miyamoto S
    J Proteome Res; 2008 Sep; 7(9):3776-88. PubMed ID: 18642944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoproteomic analysis of tissues from patients with colon cancer using lectin microarrays and nanoLC-MS/MS.
    Li Y; Wen T; Zhu M; Li L; Wei J; Wu X; Guo M; Liu S; Zhao H; Xia S; Huang W; Wang P; Wu Z; Zhao L; Shui W; Li Z; Yin Z
    Mol Biosyst; 2013 Jul; 9(7):1877-87. PubMed ID: 23567825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of multiple novel protein biomarkers shed by human serous ovarian tumors into the blood of immunocompromised mice and verified in patient sera.
    Beer LA; Wang H; Tang HY; Cao Z; Chang-Wong T; Tanyi JL; Zhang R; Liu Q; Speicher DW
    PLoS One; 2013; 8(3):e60129. PubMed ID: 23544127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of sialylated glycoproteins in ovarian cancer sera using lectin-based ELISA assay and quantitative glycoproteomics analysis.
    Wu J; Xie X; Nie S; Buckanovich RJ; Lubman DM
    J Proteome Res; 2013 Jul; 12(7):3342-52. PubMed ID: 23731285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycomic analysis of membrane glycoproteins with bisecting glycosylation from ovarian cancer tissues reveals novel structures and functions.
    Allam H; Aoki K; Benigno BB; McDonald JF; Mackintosh SG; Tiemeyer M; Abbott KL
    J Proteome Res; 2015 Jan; 14(1):434-46. PubMed ID: 25437919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oviductal glycoprotein (OVGP1, MUC9): a differentiation-based mucin present in serum of women with ovarian cancer.
    Maines-Bandiera S; Woo MM; Borugian M; Molday LL; Hii T; Gilks B; Leung PC; Molday RS; Auersperg N
    Int J Gynecol Cancer; 2010 Jan; 20(1):16-22. PubMed ID: 20130498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics.
    Narimatsu H; Sawaki H; Kuno A; Kaji H; Ito H; Ikehara Y
    FEBS J; 2010 Jan; 277(1):95-105. PubMed ID: 19919546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation.
    Armes JE; Davies CM; Wallace S; Taheri T; Perrin LC; Autelitano DJ
    Pathology; 2013 Jan; 45(1):49-54. PubMed ID: 23222243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors.
    Li QK; Shah P; Tian Y; Hu Y; Roden RBS; Zhang H; Chan DW
    Clin Proteomics; 2017; 14():16. PubMed ID: 28491011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.